Recall Z-2034-2012

Epocal Inc · initiated June 28, 2011

Class II Terminated

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

epoc Blood Analysis BGEM Test Cards for use with the epoc(R) Blood Analysis System Product Usage: Usage: epoc Blood Analysis BGEM Test Cards are used with the epoc(R) Blood Analysis System which is a POC testing system

Codes / lots: Catalog #CT-1004-00-00, lot number 07-11087-00

Reason for recall

Customer reported problem while performing incoming QC of newly received lot of test cards. Liquid quality control results were found to be out of range. Further investigation by Epocal determined that a portion of the test card lot (approximately 3000 cards) could potentially report low glucose results.

FDA-determined cause: Device Design

Action taken

Epocal Inc. sent a Voluntary Product Recall letter dated June 27, 2011 to the affected consignee. The letter identified the affected products, problem and actions to be taken. The letter ask that all products affected by this recall be sent back to Epocal and a replacement may be obtained. For questions call 1-613-738-6912.

Details

Recall number
Z-2034-2012
Initiated
June 28, 2011
Posted by FDA
July 19, 2012
Terminated
December 18, 2013
Product code
CGA – Glucose Oxidase, Glucose
Quantity
8,650
Distribution
US nationwide Distribution in the state of CA.
Recalling firm
Epocal Inc, Ottawa Canada, Ontario

Official FDA recall record